Abstracts tagged "Sjogren’s syndrome and positron emission tomography (PET)"

Abstract Number: 1560 • 2018 ACR/ARHP Annual Meeting
Usefulness of 18F-FDG Positron Emission Tomography for Lymphoma Diagnosis in Patients with Primary Sjögren’S Syndrome
Jérémy Keraen^1,2, Estelle Blanc³, Florent Besson⁴, Veronique Le Guern⁵, Rakiba Belkhir⁶, Julien Henry⁷, Céline Meyer⁴, Gaetane Nocturne⁸, Xavier Mariette⁸ and Raphaele Seror⁹, ¹Internal Medicine, CHRU Bretonneau Tours, Tours, France, ²Rheumatology, Université Paris Sud, KREMLIN BICETRE, France, ³Nuclear Medicine, Centre Chirugical Marie Lannelongue, Plessis Robinson, France, ⁴Nuclear Medicine, Kremlin Bicêtre, KREMLIN BICETRE, France, ⁵Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, Paris, France, ⁶RHEUMATOLOGY, Rheumatology, Université Paris Sud, KREMLIN BICETRE, France, ⁷Rheumatology department Assistance Publique Hôpitaux de Paris, Hôpitaux universitaires Paris-Sud, Le Kremlin-Bicêtre, Le Kremlin Bicetre, France, ⁸Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, ⁹Hopitaux Universitaires Paris Sud, Kremlin Bicetre, France, Rheumatology, Université Paris Sud, Le Kremlin Bicetre, France
Background/Purpose: primary Sjögren’s syndrome (SS) is the autoimmune disease having the highest risk of lymphoma. The differential diagnosis between benign and malignant lymphoproliferation is sometimes…
Abstract Number: 2178 • 2012 ACR/ARHP Annual Meeting
18-Fludeoxyglucose Positron Emission Tomography Is a Valuable Marker of Activity of Interstitial Lung Disease in Primary Sjogren’s Syndrome
Camille Cohen¹, Arsene Mekinian², Michael Soussan³, Yurdagul Uzunhan⁴, Veronique Eder³, Robin Dhote⁵, Dominique Valeyre⁶ and Olivier Fain⁷, ¹Jean Verdier Hospital, Bondy, France, ²Internal Medicine, Jean Verdier Hospital, Bondy, FL, France, ³Nuclear Medicine, Bobigny, France, ⁴Pneumology, Bobigny, France, ⁵Internal Medicine, Avicenne University Hospital, Bobigny, France, ⁶Department of Pneumology, Avicenne Hospital (AP-HP), Bobigny, France, ⁷Internal Medicine, Jean Verdier Hospital, Bondy, France
Background/Purpose: Purpose: To assess the value of 18-Fludeoxyglucose Positron Emission Tomography (PET) in patients with primary Sjogren's Syndrome (pSS).Methods: All patients with confirmed pSS (AECG)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].